Deformable vesicles: Alternatives in topical drug delivery

被引:0
|
作者
Nagaich, Upendra [1 ]
机构
[1] Soc Pharmaceut Educ & Res, 22-C, Gwalior 474001, Madhya Pradesh, India
关键词
D O I
10.4103/2231-4040.191413
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:117 / 117
页数:1
相关论文
共 50 条
  • [31] EPIDERMAL LIPIDS AND TOPICAL DRUG DELIVERY
    HADGRAFT, J
    WALTERS, KA
    GUY, RH
    SEMINARS IN DERMATOLOGY, 1992, 11 (02): : 139 - 144
  • [32] Topical Drug Delivery for Chronic Rhinosinusitis
    Liang J.
    Lane A.P.
    Current Otorhinolaryngology Reports, 2013, 1 (1) : 51 - 60
  • [33] Topical drug delivery to the eye: dorzolamide
    Loftsson, Thorsteinn
    Jansook, Phatsawee
    Stefansson, Einar
    ACTA OPHTHALMOLOGICA, 2012, 90 (07) : 603 - 608
  • [35] Nanoparticles and nanofibers for topical drug delivery
    Goyal, Ritu
    Macri, Lauren K.
    Kaplan, Hilton M.
    Kohn, Joachim
    JOURNAL OF CONTROLLED RELEASE, 2016, 240 : 77 - 92
  • [36] Extracellular Vesicles in HIV, Drug Abuse, and Drug Delivery
    Santosh Kumar
    Nazira El-Hage
    Elena Batrakova
    Journal of Neuroimmune Pharmacology, 2020, 15 : 387 - 389
  • [37] Extracellular Vesicles in HIV, Drug Abuse, and Drug Delivery
    Kumar, Santosh
    El-Hage, Nazira
    Batrakova, Elena
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2020, 15 (03) : 387 - 389
  • [38] Ultra deformable vesicles for boosting transdermal delivery of 2-arylpropionic acid class drug for management of musculoskeletal pain
    Shreya Kaul
    Neha Jain
    Upendra Nagaich
    Journal of Pharmaceutical Investigation, 2022, 52 : 217 - 231
  • [39] Ultra deformable vesicles for boosting transdermal delivery of 2-arylpropionic acid class drug for management of musculoskeletal pain
    Kaul, Shreya
    Jain, Neha
    Nagaich, Upendra
    JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2022, 52 (02) : 217 - 231
  • [40] Physicochernical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration
    Müller-Goymann, CC
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 58 (02) : 343 - 356